The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and activity of Combined AVElumab with Axitinib in unresectable or metastatic Thymomas B3 and Thymic carcinomas: The CAVEATT study.
 
Fabio Conforti
No Relationships to Disclose
 
Laura Pala
No Relationships to Disclose
 
Chiara Catania
No Relationships to Disclose
 
Paolo Andrea Zucali
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
 
Paolo Della Vigna
No Relationships to Disclose
 
Sara Pirola
No Relationships to Disclose
 
Sara Stucchi
No Relationships to Disclose
 
Elisabetta Pennacchioli
No Relationships to Disclose
 
Paola Queirolo
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
 
Giuseppe Giaccone
Consulting or Advisory Role - ARMO BioSciences; BerGenBio; CStone Pharmaceuticals
Research Funding - Bayer; Incyte; Lilly; MedImmune (Inst)
 
Tommaso Martino De Pas
No Relationships to Disclose